Tuesday, August 26th, 2025
Stock Profile: RVPH
RVPH Logo

Reviva Pharmaceuticals Holdings, Inc. (RVPH)

Market: NASD | Currency: USD

Address: 10080 N. Wolfe Road

Reviva Pharmaceuticals Holdings, Inc., a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. The company's lead product candidate comprises brilaroxazine (RP5063) for the treatment of various neuropsychiatric indications, including schizophrenia, bipolar disorder, major depressive disorder, attention?deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia and Alzheimer's disease, and Parkinson's disease psychosis; in clinical development respiratory indications, such as pulmonary arterial hypertension and idiopathic pulmonary fibrosis; and in preclinical development for the treatment of psoriasis. It is also developing RP1208 for the treatment of Show more




📈 Reviva Pharmaceuticals Holdings, Inc. Historical Chart






📊 Statistics





💰 Dividend History


No dividend history available.



📅 Earnings & EPS History for Reviva Pharmaceuticals Holdings, Inc.


DateReported EPS
2025-11-13 (estimated upcoming)-
2025-08-14-0.12
2025-05-15-0.13
2025-03-31-0.15
2024-11-14-0.25
2024-08-14-0.26
2024-05-14-0.25
2024-04-15-0.35
2023-11-14-0.44
2023-08-14-0.55
2023-05-15-0.3
2023-03-30-0.38
2022-11-14-0.18
2022-08-15-0.29
2022-05-16-0.4
2022-03-15-0.22
2021-11-15-0.12
2021-08-16-0.12
2021-03-22-0.17




📰 Related News & Research


No related articles found for "reviva pharmaceuticals".